BALPHARMA.NSBALPHARMA.NSNSE
Loading
Price to Sales HistoryFair Value
Percentile Rank57
3Y CAGR-8.7%
5Y CAGR+10.3%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-8.7%/yr
vs +0.8%/yr prior
5Y CAGR
+10.3%/yr
Recent deceleration
Acceleration
-9.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthFair Value
PeriodValueYoY Change
20250.43+1.2%
20240.43+23.5%
20230.35-39.2%
20220.57+84.2%
20210.31+16.9%
20200.26-40.9%
20190.45-18.7%
20180.55+1.9%
20170.54-17.7%
20160.66-